#SRZN Surrozen Announces FDA Clearance of IND Application for SZN-8141 for the Treatment of Diabetic Macular Edema

#SRZN Surrozen Announces FDA Clearance of IND Application for SZN-8141 for the Treatment of Diabetic Macular Edema
#SRZN Surrozen Announces Submission of IND Application for SZN-8141 for the Treatment of Diabetic Macular Edema